Long-Term Outcomes of Elagolix in Women With Endometriosis

Surrey, E; Taylor, HS; Giudice, L; Lessey, BA; Abrao, MS; Archer, DF; Diamond, MP; Johnson, NP; Watts, NB; Gallagher, JC; Simon, JA; Carr, BR; Dmowski, WP; Leyland, N; Singh, SS; Rechberger, T; Agarwal, SK; Duan, WR; Schwefel, B; Thomas, JW; Peloso,

Surrey, E (reprint author), Colorado Ctr Reprod Med, 10290 Ridgegate Circle, Lone Tree, CO 80124 USA.

OBSTETRICS AND GYNECOLOGY, 2018; 132 (1): 147

Abstract

OBJECTIVE: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women wit......

Full Text Link